Formulations which are resistant to gastric juice and are used to apply anti-infective compounds inhibiting the 2-c-methylerythrose-4 metabolic pathway, and the salts and esters of the same
DE10205864A1
Combination preparations, useful for the treatment of protozoal infections, especially malaria, comprise a lincosamide antibiotic such as clindamycin and a dispiro-tetraoxane compound, e.g. TetA
DE10205863A1
Combination preparations for treating protozoal infections, especially malaria, containing lincosamide antibiotic and endoperoxide antimalarial agent, e.g. clindamycin and artesunate
DE10135395A1
New acyclic or cyclic organophosphorus compounds, are gamma-delta-T cell activators useful e.g. as medicaments for treating asthma, chronic bronchitis, ulcerative colitis, autoimmune diseases or allergies
DE10134705A1
New acyclic or cyclic organophosphorus compounds, are gamma-delta-T cell activators useful e.g. as medicaments for treating asthma, chronic bronchitis, ulcerative colitis, autoimmune diseases or allergies
DE10127936A1
New organophosphorous-substituted hydroxamic acid compounds, useful as pre- or post-emergence selective herbicides in crops such as rice
AU7964901A
Use of organophosphorous hydroxamic acid derivatives for producing medicaments
DE10119905A1
Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway
MXPA01011894A
Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid.
EP1255762A1
Phosphororganic compounds and the use thereof
IL143795D0
Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections
PL349438A1
Use of bisphosphonates for the prevention and treatment of infectious processes
CZ2001989A3
Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide in plants
AU4615599A
Combined preparation of anti-infectiously active compounds which inhibit the 2-C-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
